J.P. Morgan analysts say it is too early to buy broadly into the biotechnology sector, but they identified several stocks in various categories that provide “clear opportunities” for selective investors.
Source: Some biotechnology stocks that provide ‘clear opportunities,’ J.P. Morgan says – MarketWatch
Drfinwiz's Weblog 